BackProcessa Pharmaceuticals Overview

Processa Pharmaceuticals Current Cash

Latest current cash for PCSA: $200K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$196325.00
↓ 97.17% YoYΔ $-6.74M vs prior year quarter

Peer trimmed avg / median

Loading

Processa Pharmaceuticals Current Cash History

Loading

Processa Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Processa Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Processa Pharmaceuticals (PCSA) FAQ

As of the most recent data (June 2026), PCSA shows a current cash of $200K. That compares with $6.9M in the prior-year period — down 97.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PCSA's current cash is now $200K (was $6.9M) — a 97.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Processa Pharmaceuticals is outperforming or lagging.

Tracking PCSA's current cash over time shows whether Processa Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $200K That compares with $6.9M in the prior-year period — down 97.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Processa Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $200K) with ownership activity and broader fundamentals.

Processa Pharmaceuticals's current cash is $200K; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.